Teva to pay $85m to Oklahoma over opioid case | Financial Times
Teva looks for $20B-plus from bond sale to finance Allergan deal | Fierce Pharma
Gintaras Mičiulis - Regional Finance Director Poland & CEE - Teva Pharmaceuticals | LinkedIn
Credit Line and Bonds: Teva's Financial Catch | Ctech
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Efi Benmeir - SVP Finance & CFO International Markets - Teva Pharmaceutical Industries Ltd. | LinkedIn
Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow (NYSE:TEVA) | Seeking Alpha
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters")
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Chen Zisman, PhD - Senior Director Finance - Teva Pharmaceuticals | LinkedIn
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026 | Business Wire
Highest paying jobs at Teva Pharmaceuticals
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharma Q2 Revenues Drop 18% | BioSpace
Teva Announces Appointment of New Chief Financial Officer | Business Wire
Teva exits Massachusetts as Cambridge site falls victim to restructuring - Boston Business Journal
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Abhinav Priyadarshi - Associate Director of Finance - Teva Pharmaceuticals | LinkedIn
Teva agrees $519m settlement of US anti-bribery charges | Financial Times
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Yahoo Finance on Twitter: "$TEVA Pharmaceutical is set to pay $4.25 billion in settlements in opioid cases, $CS names new CEO, $DB warns of challenging second half for 2022, and $TWTR is
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva Pharmaceutical Industries Stock Is Estimated To Be Fairly Valued
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
